~~<i id='5A8C4930F6'><strike id='5A8C4930F6'><tt id='5A8C4930F6'><pre id='5A8C4930F6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

hotspot

author：explore 2025-09-27 21:18:10 - browse：9

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Obesity drugs seen as possible treatment for liver disease MASH

knowledge

explore

knowledge

hotspot

explore

focus

WRAIRWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

WSS

Key House Republican on health care plans exit from Congress

Gilead might be held responsible for not developing a drug

Community Health Systems hospitals under DOJ investigation

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

STAT readers on older presidents, polypills, Medicare, and more

A new nitrogen execution bill also undermines medical licensing

Wikipedia

hotspot

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

The dental labor crisis is a moment of opportunity

DIEP, the 'gold standard' of breast reconstruction, is under threat

A new nitrogen execution bill also undermines medical licensing

As demand for Covid shots wanes, Moderna seeks its next success

Private equity deals in Medicare Advantage declines

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Obesity drugs seen as possible treatment for liver disease MASH

Supreme Court strikes down use of affirmative action

Medicare threatens to cut off funding for HCA's Mission hospital

explore

A new nitrogen execution bill also undermines medical licensing

STAT readers on older presidents, polypills, Medicare, and more

Obesity drugs seen as possible treatment for liver disease MASH

Biden report: The neurospychology of memory and aging

6 phony surgeries that take placebo to the extreme

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

knowledge

hotspot

explore

focus